Merck & Co. Inc. (MRK:NYSE)

Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter fell $.62 or 1.1 percent, to $54.33. Bristol-Myers Squibb rose $.43 or 1.8 percent, to $24.46. Hospira fell $.23 or .5 percent, to $46.88. Johnson & Johnson rose $.37 or .6 percent, to $62.31. King Pharmaceuticals rose $.04 or .3 percent, to $11.80. Eli Lilly rose $.47 or 1.3 percent, to $36.59. Merck rose $...

Shares of some top pharmaceuticals companies are mixed at noon: Baxter fell $.56 or 1.0 percent, to $54.39. Bristol-Myers Squibb rose $.11 or .5 percent, to $24.14. Hospira fell $.40 or .8 percent, to $46.71. Johnson & Johnson rose $.32 or .5 percent, to $62.26. King Pharmaceuticals rose $.18 or 1.5 percent, to $11.94. Eli Lilly rose $.29 or .8 percent, to $36.41. Merck rose $.86 or 2.4 percent...

Drug developer Merck & Co. said Friday a European advisory committee recommended approval for the company's fertility drug Elonva. The Committee for Medicinal Products for Human Use of The European Medicines Agency made the recommendation. Shares of Merck rose 65 cents to $35.98 in morning trading.

Shares of some top pharmaceuticals companies are mixed at 10 a.m.: Baxter fell $.13 or .2 percent, to $54.82. Bristol-Myers Squibb rose $.08 or .3 percent, to $24.11. Hospira fell $.27 or .6 percent, to $46.84. Johnson & Johnson rose $.20 or .3 percent, to $62.14. King Pharmaceuticals rose $.04 or .3 percent, to $11.80. Eli Lilly rose $.04 or .1 percent, to $36.16. Merck rose $.64 or 1.8 percen...

Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of ELONVA® as a treatment in controlled ovarian stimulation in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology program.

The FDA has so far failed to craft rules clarifying how drug companies can participate in online discussions

The FDA has so far failed to craft rules clarifying how companies can participate in online discussions

Shares of some top pharmaceuticals companies are mixed at noon: Baxter fell $.61 or 1.1 percent, to $55.07. Bristol-Myers Squibb fell $.50 or 2.0 percent, to $24.02. Hospira fell $.65 or 1.4 percent, to $47.03. Johnson & Johnson fell $.49 or .8 percent, to $61.83. King Pharmaceuticals rose $.68 or 6.1 percent, to $11.87. Eli Lilly fell $.47 or 1.3 percent, to $35.74. Merck rose $.37 or 1.1 perc...

Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to fully replace revenue from best-sellers that go off-patent.